Market1 Monat ago
MRNA Stock Up 14% in Pre-Market as Moderna COVID-19 Vaccine Hits 94.5% Efficacy
The Moderna vaccine trial involved about 30,000 participants and the interim analysis for the vaccine was based on 95 infections among the trial participants The stock...
Neueste Kommentare